265 related articles for article (PubMed ID: 29233161)
21. Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer.
Zhang Z; Ma J; Li N; Sun N; Wang C
Ann Thorac Surg; 2006 Jul; 82(1):243-8. PubMed ID: 16798222
[TBL] [Abstract][Full Text] [Related]
22. miR-675 promotes disease progression of non-small cell lung cancer via activating NF-κB signaling pathway.
Feng Y; Yang C; Hu D; Wang X; Liu X
Cell Mol Biol (Noisy-le-grand); 2017 May; 63(5):7-10. PubMed ID: 28719338
[TBL] [Abstract][Full Text] [Related]
23. Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo.
Weng MC; Li MH; Chung JG; Liu YC; Wu JY; Hsu FT; Wang HE
Biomed Pharmacother; 2019 Aug; 116():109032. PubMed ID: 31163381
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of P21-activated kinase 4 is associated with poor prognosis in non-small cell lung cancer and promotes migration and invasion.
Cai S; Ye Z; Wang X; Pan Y; Weng Y; Lao S; Wei H; Li L
J Exp Clin Cancer Res; 2015 May; 34(1):48. PubMed ID: 25975262
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic downregulated ITGBL1 promotes non-small cell lung cancer cell invasion through Wnt/PCP signaling.
Gan X; Liu Z; Tong B; Zhou J
Tumour Biol; 2016 Feb; 37(2):1663-9. PubMed ID: 26307393
[TBL] [Abstract][Full Text] [Related]
26. Combined prognostic value of both RelA and IkappaB-alpha expression in human non-small cell lung cancer.
Zhang D; Jin X; Wang F; Wang S; Deng C; Gao Z; Guo C
Ann Surg Oncol; 2007 Dec; 14(12):3581-92. PubMed ID: 17899287
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of IL-11, an IL-6 Family Cytokine, Promotes Tumor Progression and Correlates with Poor Prognosis in Non-Small Cell Lung Cancer.
Zhao M; Liu Y; Liu R; Qi J; Hou Y; Chang J; Ren L
Cell Physiol Biochem; 2018; 45(6):2213-2224. PubMed ID: 29550807
[TBL] [Abstract][Full Text] [Related]
28. [Expression and clinical significance of BCL6 corepressor-like 1 in non-small cell lung cancer].
Zhao X; Tuo H; Si M; Wang L; Liang P
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Dec; 31(12):1677-81. PubMed ID: 26648304
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-7 inhibits cell proliferation, migration and invasion in human non-small cell lung cancer cells by targeting FAK through ERK/MAPK signaling pathway.
Cao Q; Mao ZD; Shi YJ; Chen Y; Sun Y; Zhang Q; Song L; Peng LP
Oncotarget; 2016 Nov; 7(47):77468-77481. PubMed ID: 27764812
[TBL] [Abstract][Full Text] [Related]
30. Down-regulation of LATS2 in non-small cell lung cancer promoted the growth and motility of cancer cells.
Yao F; Liu H; Li Z; Zhong C; Fang W
Tumour Biol; 2015 Mar; 36(3):2049-57. PubMed ID: 25391426
[TBL] [Abstract][Full Text] [Related]
31. Homeobox A9 directly targeted by miR-196b regulates aggressiveness through nuclear Factor-kappa B activity in non-small cell lung cancer cells.
Yu SL; Lee DC; Sohn HA; Lee SY; Jeon HS; Lee JH; Park CG; Lee HY; Yeom YI; Son JW; Yoon YS; Kang J
Mol Carcinog; 2016 Dec; 55(12):1915-1926. PubMed ID: 26586336
[TBL] [Abstract][Full Text] [Related]
32. SMYD3 overexpression indicates poor prognosis and promotes cell proliferation, migration and invasion in non‑small cell lung cancer.
Li J; Zhao L; Pan Y; Ma X; Liu L; Wang W; You W
Int J Oncol; 2020 Sep; 57(3):756-766. PubMed ID: 32705243
[TBL] [Abstract][Full Text] [Related]
33. Hyperforin Suppresses Tumor Growth and NF-κB-mediated Anti-apoptotic and Invasive Potential of Non-small Cell Lung Cancer.
Chen WT; Chen YK; Lin SS; Hsu FT
Anticancer Res; 2018 Apr; 38(4):2161-2167. PubMed ID: 29599335
[TBL] [Abstract][Full Text] [Related]
34. SET domain containing protein 5 (SETD5) enhances tumor cell invasion and is associated with a poor prognosis in non-small cell lung cancer patients.
Yu H; Sun J; Zhao C; Wang H; Liu Y; Xiong J; Chang J; Wang M; Wang W; Ye D; Zhou H; Yu T
BMC Cancer; 2019 Jul; 19(1):736. PubMed ID: 31345185
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of ADAMTS5 can regulate the migration and invasion of non-small cell lung cancer.
Gu J; Chen J; Feng J; Liu Y; Xue Q; Mao G; Gai L; Lu X; Zhang R; Cheng J; Hu Y; Shao M; Shen H; Huang J
Tumour Biol; 2016 Jul; 37(7):8681-9. PubMed ID: 26738863
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of integrin-linked kinase correlates with malignant phenotype in non-small cell lung cancer and promotes lung cancer cell invasion and migration via regulating epithelial-mesenchymal transition (EMT)-related genes.
Chen D; Zhang Y; Zhang X; Li J; Han B; Liu S; Wang L; Ling Y; Mao S; Wang X
Acta Histochem; 2013 Mar; 115(2):128-36. PubMed ID: 22683084
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC).
Zhang JG; Wang JJ; Zhao F; Liu Q; Jiang K; Yang GH
Clin Chim Acta; 2010 Jun; 411(11-12):846-52. PubMed ID: 20223231
[TBL] [Abstract][Full Text] [Related]
39. Nuclear HDAC6 inhibits invasion by suppressing NF-κB/MMP2 and is inversely correlated with metastasis of non-small cell lung cancer.
Yang CJ; Liu YP; Dai HY; Shiue YL; Tsai CJ; Huang MS; Yeh YT
Oncotarget; 2015 Oct; 6(30):30263-76. PubMed ID: 26388610
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of EI2BL promoted human non-small cell lung cancer progression by inducing cell EMT phenotype.
Li HR; Qiu BQ; Gao J; Jin C; Jiang JH; Ding JY
J Clin Pathol; 2020 Mar; 73(3):139-146. PubMed ID: 31586937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
